Witte Katrin, et al.
PloS one, 2015
Abstract
Pelargonium sidoides is a medical herb and respective extracts are used very frequently for the treatment of respiratory tract infections. However, the effects of Pelargonium sidoides and a special extract prepared from its roots (EPs 7630) on human immune cells are not fully understood. Here we demonstrate that EPs 7630 induced a rapid and dose-dependent production of TNF-α, IL-6, and IL-10 by human blood immune cells. This EPs 7630-induced cytokine profile was more pro-inflammatory in comparison with the profile induced by viral or bacterial infection-mimicking agents. The search for EPs 7630 target cells revealed that T-cells did not respond to EPs 7630 stimulation by production of TNF-α, IL-6, or IL-10. Furthermore, pretreatment of T-cells with EPs 7630 did not modulate their TNF-α, IL-6, and IL-10 secretion during subsequent activation. In contrast to lymphocytes, monocytes showed clear intracellular TNF-α staining after EPs 7630 treatment. Accordingly, EPs 7630 predominantly provoked activation of MAP kinases and inhibition of p38 strongly reduced the monocyte TNF-α production. The pretreatment of blood immune cells with EPs 7630 lowered their secretion of TNF-α and IL-10 and caused an IL-6 dominant response during second stimulation with viral or bacterial infection-mimicking agents. In summary, we demonstrate that EPs 7630 activates human monocytes, induces MAP kinase-dependent pro-inflammatory cytokines in these cells, and specifically modulates their production capacity of mediators known to lead to an increase of acute phase protein production in the liver, neutrophil generation in the bone marrow, and the generation of adaptive Th17 and Th22 cells.
Conflict of interest statement
Competing Interests: The authors have the following interests. This study was funded by Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany, the employer of Egon Koch. Dr. Willmar Schwabe GmbH & Co. KG, also provided support in the form of research material (EPs 7630). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.| PMID: | 26406906 |
|---|---|
| PMCID (Free PMC Article): | PMC4583277 |
| DOI: | 10.1371/journal.pone.0138075 |
| Category: | Allergy / Immune |
| Category: | Cold / Flu |
Articles similar to "The Pelargonium Sidoides Extract EPs 7630 Drives the Innate Immune Defense by Activating Selected MAP Kinase Pathways in Human Monocytes."
- The role of Pelargonium Sidoides in Allergy / Immune: Can the Pelargonium Sidoides Root Extract EPs® 7630 Prevent Asthma Attacks During Viral Infections of the Upper Respiratory Tract in Children?. (Introduction: Asthma is a chronic disease characterized by airway inflammation...)
- The impact of Pelargonium Sidoides on Cold / Flu: Efficacy of Proanthocyanidins From Pelargonium sidoides Root Extract in Reducing P. gingivalis Viability While Preserving Oral Commensal S. salivarius. (Bacterial resistance to antibiotics and the disruption of beneficial microbiota are key problems in contemporary medicine and make the search for new, more efficient infection treatment strategies among the most important tasks in medicine...)
- The significance of Pelargonium Sidoides for Cold / Flu: Investigation of Antibacterial and Antiinflammatory Activities of Proanthocyanidins From Pelargonium sidoides DC Root Extract. (The study explores antibacterial, antiinflammatory and cytoprotective capacity of Pelargonium sidoides DC root extract (PSRE) and proanthocyanidin fraction from PSRE (PACN) under conditions characteristic for periodontal disease...)
- The impact of Pelargonium Sidoides on Cold / Flu: The Efficacy of Pelargonium Sidoides in the Treatment of Upper Respiratory Tract Infections in Children With Transient Hypogammaglobulinemia of Infancy. (Transient hypogammaglobulinemia of infancy (THI), defined as prolongation of physiological hypogammaglobulinemia normally seen between the initial 3rd and 6th months of life, is one of the most common immune deficiencies of childhood...)
- The significance of Pelargonium Sidoides for Cold / Flu: Efficacy of a Pelargonium Sidoides Preparation in Patients With the Common Cold: A Randomized, Double Blind, Placebo-Controlled Clinical Trial. ( The common cold is a viral infection with symptoms such as sneezing, sore throat, and running nose... EPs represents an effective treatment of the common cold. It significantly reduces the severity of symptoms and shortens the duration of the common cold compared with placebo. The herbal drug is well tolerated.)
- The role of Pelargonium Sidoides in Cold / Flu: Efficacy and Tolerability of EPs 7630 Tablets in Patients With Acute Bronchitis: A Randomised, Double-Blind, Placebo-Controlled Dose-Finding Study With a Herbal Drug Preparation From Pelargonium Sidoides. (Objective: Acute bronchitis is one of the most frequent health complaints for which patients seek medical advice... This study demonstrated statistically significant and clinically relevant superiority of all three tested dosages of EPs 7630 over placebo. All dosages of EPs 7630 were well-tolerated. Taking into account both efficacy and safety, the results of this study indicate that the 20 mg tablets of EPs 7630 taken three times daily constitute the optimal dose with respect to the benefit-risk ratio.)
- The impact of Pelargonium Sidoides on Cold / Flu: Treatment of Acute Bronchitis in Adults With a Pelargonium Sidoides Preparation (EPs® 7630): A Randomized, Double-Blind, Placebo-Controlled Trial. ( Acute bronchitis is a widespread medical problem, and, although predominantly caused by viruses, antibiotics are still prescribed unnecessarily... EPs 7630 was superior in efficacy compared with placebo in the treatment of adults with acute bronchitis. It may therefore offer an effective alternative for acute bronchitis unless antibiotics are clearly indicated.)